Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
158.11B
Market cap158.11B
Price-Earnings ratio
36.63
Price-Earnings ratio36.63
Dividend yield
6.22%
Dividend yield6.22%
Average volume
34.37M
Average volume34.37M
High today
$27.92
High today$27.92
Low today
$27.53
Low today$27.53
Open price
$27.64
Open price$27.64
Volume
28.77M
Volume28.77M
52 Week high
$29.21
52 Week high$29.21
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $27.79, with a market capitalization of 158.11B. The stock trades at a price-to-earnings (P/E) ratio of 36.63 and offers a dividend yield of 6.22%.

On 2026-09-21, Pfizer(PFE) stock traded between a low of $27.53 and a high of $27.92. Shares are currently priced at $27.79, which is +1.0% above the low and -0.5% below the high.

The Pfizer(PFE)'s current trading volume is 28.77M, compared to an average daily volume of 34.37M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.

In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.

PFE News

TipRanks 10h
Pfizer’s Rimegepant Trial Targets Chronic Migraine Market Upside

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a phase 3 study called “An interventional efficacy and safet...

TipRanks 10h
Pfizer Advances PF-07799544 With Completion of Key Phase 1 Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has completed a Phase 1 study titled “A PHASE 1, OPEN-LABEL, FIXED SEQU...

Nasdaq 1d
Pfizer Says Its Biggest Headwinds Are Finally Easing. Does That Change the Story for This Ultra-High-Yield Dividend Stock?

Key Points Pfizer has made significant progress in addressing some of its challenges. However, the company still has a rocky road ahead. Launching newer medi...

Pfizer Says Its Biggest Headwinds Are Finally Easing. Does That Change the Story for This Ultra-High-Yield Dividend Stock?

Analyst ratings

61%

of 28 ratings
Buy
32.1%
Hold
60.7%
Sell
7.1%

More PFE News

TipRanks 1d
Pfizer to share portion of increased revenue to U.S. HHS, Bloomberg says

The U.S. Department of Health and Human Services, HHS, will receive a portion of the increased revenue if Pfizer (PFE) raises its drug prices abroad, Rachel Coh...

Simply Wall St 2d
Will Conference Outlook Change Pfizer Stock Narrative

Pfizer recently presented at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, with CEO Albert Bourla outlining how the business is handl...

Will Conference Outlook Change Pfizer Stock Narrative
Nasdaq 2d
Is Pfizer an Excellent Dividend Stock to Buy?

Pfizer (NYSE: PFE) has experienced unprecedented circumstances in the previous decade. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think the...

Is Pfizer an Excellent Dividend Stock to Buy?
24/7 Wall St. 3d
Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?

Investing Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing? Pfizer has raised its dividend every year for over a decade, then something chan...

Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?
TipRanks 4d
Health Canada authorizes Pfizer, BioNTech’s Omicron XFG-adapted Covid-19 vaccine

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the XFG variant-adapted COMIRNATY for active immunization of individuals age...

Nasdaq 5d
Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

Key Points Pfizer's management remains firmly committed to maintaining the dividend. The company's growth portfolio is performing well. Pfizer's cash stockpi...

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.